Agree with all of these points on key data Boffin, would suggest there could be others to add to this list, such as:
- Under FTO - The 100 plus cancer screening results.
- As a Wild Card - Coming from yet unknown/unexpected academic research results/findings on FTO (using CS1/Zantrene) in areas outside of cancer, e.g. type 2 diabetes or neurologic disease.
Ann: Race continues Board renewal - appoints new Chair, page-101
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.035(2.07%) |
Mkt cap ! $282.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $122.2K | 73.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6835 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 2384 | 2 |
View Market Depth
| Last trade - 13.38pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |